Internal Medicine, Infectious Disease · Cincinnati, OH
NPI
1639554538
Since 2015
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
234 Goodman St
Cincinnati, OH, 45219
Phone (513) 558-4704
Groups this clinician bills Medicare through
Medicare paid, 2024
$20K
211 services
Medicare patients, 2024
103
Average age 67
Drug cost, 2024
$1.3M
438 prescriptions
Company payments
-
None reported
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Kavya B Patel was code 99233 (hospital e&m - subsequent), 77 times for 40 patients. In total Kavya B Patel billed 211 services in 11 codes, and Medicare paid $20K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-06-18.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99233 Hospital E&M - Subsequent | Facility | 77 | 40 | $89.17 | $6,866 |
| 99223 Hospital E&M - Initial | Facility | 58 | 55 | $128.66 | $7,462 |
| 99232 Hospital E&M - Subsequent | Facility | 38 | 27 | $56.07 | $2,131 |
| 99222 Hospital E&M - Initial | Facility | 14 | 14 | $99.04 | $1,387 |
By year: 2022 $20K for 224 services; 2023 $19K for 222 services; 2024 $20K for 211 services.
Medicare prescription drug claims, 2024
In 2024, the drug Kavya B Patel prescribed most often to Medicare patients was Biktarvy (Bictegrav/Emtricit/Tenofov Ala), with 72 prescriptions and refills. In total Kavya B Patel wrote 438 Medicare prescriptions that cost $1.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 72 | 72 | 12 | $286K |
| Zerbaxa Ceftolozane/Tazobactam | 51 | 51 | Under 11 | $360K |
| Tivicay Dolutegravir Sodium | 22 | 22 | Under 11 | $49K |
| Cefepime Hcl Generic | 20 | 20 | Under 11 | $12K |
| Livtencity Maribavir | 18 | 18 | Under 11 | $459K |
| Isoniazid Generic | 17 | 19 | Under 11 | $113 |
| Daptomycin Generic | 16 | 16 | Under 11 | $34K |
| Doxycycline Hyclate Generic | 14 | 20 | Under 11 | $417 |
| Itraconazole Generic | 14 | 14 | Under 11 | $703 |
| Ciprofloxacin Hcl Generic | 11 | 11 | Under 11 | $104 |
| Amoxicillin Generic | 11 | 11 | Under 11 | $93.54 |
| Triumeq Abacavir/Dolutegravir/Lamivudi | 11 | 15 | Under 11 | $55K |
Brand drugs: 220 claims; generic drugs: 218 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Kavya B Patel were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.